Lotus Eye Hospital and Institute
NSE: LOTUSEYE · ISIN INE947I01017 · Healthcare
₹103.99+0.00 (+0.00%)
Monday 9 November, 12:05 IST. Delayed. Source: Yahoo Finance.
Price chart
₹103.99 +0.00 (+0.00%) today
The day
- Previous close
- ₹103.99
- Open
- ₹104.00
- Day high
- ₹106.80
- Day low
- ₹103.00
Listed on NSE since 11 July 2008.
Key numbers
- Market value
- ₹216.26 Cr
- P/E (trailing)
- 1,299.88
- EPS (trailing)
- ₹0.08
- Price to book
- 3.68
- Dividend yield
- 0.00%
- Debt to equity
- 0.26
- Profit margin
- 0.3%
- Beta
- 0.60
- Volume today
- 3,608
- Average volume
- 15,720
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹45.98 Cr | ₹4.08 Cr |
| FY24 | ₹47.24 Cr | ₹2.91 Cr |
| FY25 | ₹48.60 Cr | ₹73.93 L |
| FY26 | ₹52.48 Cr | ₹8.04 L |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹17 Cr | ₹61.37 L | +12.6% |
| Q4 FY26Jan–Mar 2026Audited | ₹14 Cr | ₹-31.95 L | −226.6% |
| Q3 FY26Oct–Dec 2025 | ₹14 Cr | ₹-26.07 L | – |
| Q2 FY26Jul–Sep 2025 | ₹13 Cr | ₹11.58 L | – |
| Q1 FY26Apr–Jun 2025 | ₹14 Cr | ₹54.48 L | – |
| Q4 FY25Jan–Mar 2025Audited | ₹12 Cr | ₹25.23 L | – |
Source: Lotus Eye Hospital and Institute’s results filed with NSE, standalone (the company alone). Net profit is the share of Lotus Eye Hospital and Institute’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹59 Cr | ₹48 Cr |
| Inventories | ₹4 Cr | ₹4 Cr |
| Owed by customers | ₹1 Cr | ₹1 Cr |
| Cash and equivalents | ₹2 Cr | ₹1 Cr |
| Total assets | ₹83 Cr | ₹72 Cr |
| Borrowings | ₹11 Cr | ₹0 |
| Total liabilities | ₹22 Cr | ₹11 Cr |
| Shareholders’ equity | ₹60 Cr | ₹61 Cr |
Source: Lotus Eye Hospital and Institute’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Lotus Eye Hospital and Institute
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch-free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive errors, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and corneal infections, as well as various eye-related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
- Industry
- Medical Care Facilities
- Based in
- Coimbatore
- Employees
- 402
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Lotus Eye Hospital and Institute in the last day or two.
Dividends and corporate actions
All companies- Annual General Meeting
Action · ex-date 18 September 2023
- Dividend - Re 0.50 Per Share
Dividend · ex-date 18 September 2023
- Annual General Meeting/Dividend - Re 0.50 Per Sh
Dividend · ex-date 8 September 2022
- Annual General Meeting/Dividend - Rs 0.50 Per Share
Dividend · ex-date 8 September 2021
- Annual General Meeting
Action · ex-date 19 November 2020
- Annual General Meeting
Action · ex-date 16 September 2019
- Annual General Meeting/Dividend Re 0.5 Per Share
Dividend · ex-date 14 September 2018
- Annual General Meeting/Dividend Re 0.5 Per Share
Dividend · ex-date 14 September 2018
Source: NSE. Latest first, 8 of 18.
Information only, not investment advice. Prices are delayed.